Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Some gonadal hormone drugs can block filovirus entry into cells.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Certain drugs that block specific enzymes can help treat prostate diseases.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

The new compound may be a safer alternative to finasteride for prostate protection.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Combining ciprofloxacin with other treatments may improve its effectiveness against resistant bacteria.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.